双鹭药业 (002038.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(双鹭药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 245,116,238.481,018,358,696.85776,629,583.53583,506,665.49296,576,777.051,050,165,426.33826,971,410.27554,215,134.55274,551,424.02
 营业利润(元) 71,156,814.33477,869,983.57344,612,259.87350,358,045.79230,848,992.92263,317,181.59249,910,918.77173,159,717.1665,895,515.93
 利润总额(元) 71,158,314.34464,894,309.39344,637,149.36350,374,147.81230,847,893.29259,351,797.45249,916,261.73173,155,394.8365,895,515.94
 净利润(元) 69,675,806.49414,957,464.48316,227,670.71316,179,332.84201,680,302.96228,342,028.61234,860,671.21163,268,056.7862,249,029.27
 归属于母公司股东的净利润(元) 70,134,618.06416,691,942.89317,568,080.90317,164,126.27201,929,706.82234,404,162.05237,948,276.96165,327,395.9563,295,907.68
盈利能力:
 销售毛利率(%) 76.3381.5680.5283.3686.1185.0584.1984.3982.51
 销售净利率(%) 28.4340.7540.7254.1968.0021.7428.4029.4622.67
 净资产收益率(%) 1.227.405.715.743.66----
 总资产报酬率ROA(%) 1.117.415.575.763.83----
 投入资本回报率ROIC(%) 1.197.375.705.693.634.354.423.091.18
营运能力:
 存货周转率(次) 0.331.341.030.620.25----
 应收账款周转率(次) 1.164.503.322.321.06----
 总资产周转率(次) 0.040.170.130.100.05----
偿债能力:
 资产负债率(%) 6.857.456.186.486.686.757.247.057.05
 股东权益比率(%) 93.0192.4093.6693.3693.1293.0692.5692.7392.68
 已获利息倍数(倍) -30.13-30.32-28.59-40.73-72.53-16.39-14.14-14.84-14.37
 流动比率 7.677.077.857.377.296.927.437.637.67
 速动比率 6.546.366.826.356.176.026.466.626.71
发展能力:
 营业收入增长率(%) -17.35-3.03-6.095.298.02-13.55-9.46-11.268.59
 营业利润增长率(%) -69.1881.4837.89102.33250.33-42.45-47.76-48.38-37.04
 税后利润增长率(%) -65.2777.7733.4691.84219.02-44.97-45.42-45.17-31.07
 净资产增长率(%) 3.546.084.315.715.512.952.741.965.60
 总资产增长率(%) 3.666.843.085.005.022.002.711.475.11

前瞻产业研究院